P. de la Cueva

Infections in Moderate to Severe Psoriasis Patients Treated with Biological Drugs Compared to Classic Systemic Drugs: Findings from the BIOBADADERM Registry

P. Dávila‐Seijo, E. Daudén, M.Á. Descalzo et al. · Journal of Investigative Dermatology · 2016 · 123 citations · Full text

Classic Systemic Drugs, Psoriatic Arthritis, Clinical Dermatology +6

Survival of classic and biological systemic drugs in psoriasis: results of the <scp>BIOBADADERM</scp> registry and critical analysis

P. Dávila‐Seijo, E. Daudén, G. Carretero et al. · Journal of the European Academy of Dermatology and Venereology · 2016 · 97 citations

Genetic variation at the glycosaminoglycan metabolism pathway contributes to the risk of psoriatic arthritis but not psoriasis

Adrià Aterido, Juan D. Cañete, Jesús Tornero et al. · Annals of the Rheumatic Diseases · 2018 · 75 citations

Risk of adverse events in psoriasis patients receiving classic systemic drugs and biologics in a 5‐year observational study of clinical practice: 2008–2013 results of the Biobadaderm registry

G. Carretero, E. Daudén, Francisco Vanaclocha Sebastián et al. · Journal of the European Academy of Dermatology and Venereology · 2014 · 65 citations · Full text

Spanish Evidence-Based Guidelines on the Treatment of Psoriasis With Biologic Agents, 2013. Part 1: On Efficacy and Choice of Treatment

L. Puig, J.M. Carrascosa, G. Carretero et al. · Actas Dermo-Sifiliográficas · 2013 · 62 citations · Full text